A broadly neuroprotective derivative of curcumin
@article{Liu2008ABN, title={A broadly neuroprotective derivative of curcumin}, author={Yuanbin Liu and Richard Dargusch and Pamela Maher and David R. Schubert}, journal={Journal of Neurochemistry}, year={2008}, volume={105} }
The plant polyphenolic curcumin alters the response of nerve cells to some forms of toxic stress. The steroid‐like compound, cyclohexyl bisphenol A, has broad neuroprotective properties that are very distinct from those of curcumin. To incorporate both families of biological activities into a single molecule, a pyrazole derivative of curcumin, called CNB‐001, was synthesized. CNB‐001 acquires a new activity and is far superior in neuroprotection assays to either parental molecule, but retains…
98 Citations
Clinical development of curcumin in neurodegenerative disease
- BiologyExpert review of neurotherapeutics
- 2015
This review addresses the rationale for its use in neurodegenerative disease, particularly Alzheimer’s disease, and examines curcumin's role in wound repair, cancer and inflammatory disorders.
Usefulness of Curcumin Analogs for the Diagnosis and Treatment of Alzheimer Disease
- BiologyCurcumin for Neurological and Psychiatric Disorders
- 2019
A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine
- Chemistry, BiologyJournal of Molecular Neuroscience
- 2015
T-006 significantly ameliorated memory impairments in APP/PS1 transgenic mice and multiple functions of a single molecule suggest that T-006 is a promising novel neuroprotective agent for treating various neurodegenerative disorders, including and in particular Alzheimer's disease.
Therapeutic Potentials of Curcumin in Parkinson’s Disease
- BiologyCurcumin for Neurological and Psychiatric Disorders
- 2019
J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox™ Safety and Genotoxicity Analysis
- BiologyJournal of neurology & neurophysiology
- 2013
There is a significant therapeutic safety window for J-147 and it should be further developed as a novel neuroprotective-neurotrophic agent to treat neurodegenerative disease taking into account current National Institute of Neurological Disorders and Stroke (NINDS) RIGOR guidelines.
Neuroprotective Effect of CNB-001, a Novel Pyrazole Derivative of Curcumin on Biochemical and Apoptotic Markers Against Rotenone-Induced SK-N-SH Cellular Model of Parkinson’s Disease
- BiologyJournal of Molecular Neuroscience
- 2013
The results suggest that CNB-001 protects neuronal cell against toxicity through antioxidant and antiapoptotic properties through its action on mitochondria and can be further developed as a promising drug for treatment of PD.
Synthesis of novel steroidal curcumin derivatives as anti-Alzheimer’s disease candidates: Evidences-based on in vivo study
- Biology, ChemistrySteroids
- 2015
Development of bivalent compounds as potential neuroprotectants for Alzheimer's disease.
- Biology, ChemistryBioorganic & medicinal chemistry letters
- 2019
References
SHOWING 1-10 OF 61 REFERENCES
Anticancer potential of curcumin: preclinical and clinical studies.
- BiologyAnticancer research
- 2003
Evidence has also been presented to suggest that curcumin can suppress tumor initiation, promotion and metastasis, and Pharmacologically,Curcumin has been found to be safe.
Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses
- BiologyTrends in Neurosciences
- 2006
Neuroprotective effects of curcumin.
- BiologyAdvances in experimental medicine and biology
- 2007
Accumulating cell culture and animal model data show that dietary curcumin is a strong candidate for use in the prevention or treatment of major disabling age-related neurodegenerative diseases like Alzheimer's, Parkinson's, and stroke.
A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid‐β oligomeric complexes
- Biology, ChemistryJournal of neurochemistry
- 2006
A cell‐permeable tricyclic pyrone named CP2 is identified that ameliorates this toxicity of amyloid‐β protein and significantly reduces the levels of Aβ‐OCs.
Pharmacokinetics and pharmacodynamics of curcumin.
- Biology, MedicineAdvances in experimental medicine and biology
- 2007
Curcumin's ability to alter gene transcription and induce apoptosis in preclinical models advocates its potential utility in cancer chemoprevention and chemotherapy.
Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid.
- Biology, ChemistryJournal of agricultural and food chemistry
- 2005
Conclusively, morin or quercetin could be a key molecule for the development of therapeutics for AD, and curcuminoids, flavone type flavonoids, and naphthoquinones were shown to be potent inhibitors of betaA fibrilization.
Structure–activity Relationships of Amyloid Beta‐aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility
- Biology, ChemistryChemical biology & drug design
- 2007
The effect of three prominent features on inhibition of amyloid aggregation: the presence of two aromatic end groups, the substitution pattern of these aromatics, and the length and flexibility of the linker region are surveyed.
Structure-antioxidant activity relationships of flavonoids and phenolic acids.
- Chemistry, MedicineFree radical biology & medicine
- 1996
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
- BiologyThe Journal of Neuroscience
- 2001
Low and high doses of curcumin significantly lowered oxidized proteins and interleukin-1β, a proinflammatory cytokine elevated in the brains of these mice, and shows promise for the prevention of Alzheimer's disease.
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
- BiologyNeurobiology of Aging
- 2001